Australia markets close in 1 hour 36 minutes

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
19.95-0.02 (-0.10%)
At close: 04:00PM EST
19.95 0.00 (0.00%)
After hours: 04:20PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 537.40M
Enterprise value 322.18M
Trailing P/E 478.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.77
Price/book (mrq)1.39
Enterprise value/revenue 1.68
Enterprise value/EBITDA -5.08

Trading information

Stock price history

Beta (5Y monthly) 0.96
52-week change 3-16.13%
S&P500 52-week change 316.58%
52-week high 329.59
52-week low 39.26
50-day moving average 316.32
200-day moving average 318.91

Share statistics

Avg vol (3-month) 3253.12k
Avg vol (10-day) 3192.77k
Shares outstanding 526.91M
Implied shares outstanding 626.91M
Float 825.97M
% held by insiders 14.48%
% held by institutions 185.72%
Shares short (14 Nov 2023) 41.3M
Short ratio (14 Nov 2023) 43.98
Short % of float (14 Nov 2023) 45.79%
Short % of shares outstanding (14 Nov 2023) 44.85%
Shares short (prior month 12 Oct 2023) 41.11M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin -39.32%
Operating margin (ttm)-15.68%

Management effectiveness

Return on assets (ttm)-11.95%
Return on equity (ttm)-18.94%

Income statement

Revenue (ttm)192.01M
Revenue per share (ttm)7.21
Quarterly revenue growth (yoy)66.10%
Gross profit (ttm)105.03M
Net income avi to common (ttm)-75.5M
Diluted EPS (ttm)-2.84
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)229.75M
Total cash per share (mrq)8.54
Total debt (mrq)14.56M
Total debt/equity (mrq)3.78%
Current ratio (mrq)7.70
Book value per share (mrq)14.35

Cash flow statement

Operating cash flow (ttm)-30.21M
Levered free cash flow (ttm)-15.35M